Literature DB >> 6999984

New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

T Murakawa, H Sakamoto, T Hirose, M Nishida.   

Abstract

A new in vitro model was devised for evaluating the bactericidal activity of antibiotics under dynamic conditions. This model accurately reproduced the observed serum levels of antibiotics after intravenous dosing. The apparatus consists of two vessels which correspond to the central and peripheral compartments of a two-compartment open model. The volume of medium in each vessel and flow rates of media were determined from the pharmacokinetic parameters calculated from the observed serum levels selected for simulation. The bactericidal activity of cefazolin against strains of Escherichia coli and Klebsiella pneumoniae showing different minimal inhibitory concentrations was investigated with the apparatus simulating serum levels after intravenous injection, and the bactericidal activity was evaluated with respect to the relationship between the minimal inhibitory concentration and the serum levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999984      PMCID: PMC284009          DOI: 10.1128/AAC.18.3.377

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Action of Penicillin on Staphylococcus.

Authors:  R F Parker; H C Marsh
Journal:  J Bacteriol       Date:  1946-02       Impact factor: 3.490

2.  Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Am J Med       Date:  1950-09       Impact factor: 4.965

3.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection.

Authors:  M J Al-Asadi; D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

5.  Pharmacology of cefazolin in patients with normal and abnormal renal function.

Authors:  M E Levison; S P Levison; K Ries; D Kaye
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin.

Authors:  C S Goodwin; E B Raftery; A D Goldberg; H Skeggs; A E Till; C M Martin
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

7.  In vitro activity and clinical pharmacology of cefamandole in comparison to cephalothin.

Authors:  V C Simon; V Malerczyk; F Nixdorf
Journal:  J Antimicrob Chemother       Date:  1978-01       Impact factor: 5.790

8.  Bactericidal activity of cephalosporins in an in vitro model simulating serum levels.

Authors:  M Nishida; T Murakawa; T Kamimura; N Okada
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

9.  New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

Authors:  S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

10.  Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.

Authors:  F Leitner; R A Goodhines; R E Buck; K E Price
Journal:  J Antibiot (Tokyo)       Date:  1979-07       Impact factor: 2.649

View more
  17 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model.

Authors:  A A Firsov; V M Chernykh; S M Navashin
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

3.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Artifacts in dilution pharmacokinetic models caused by adherent bacteria.

Authors:  R Haag; P Lexa; I Werkhäuser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Correction for bacterial loss in in vitro dilution models.

Authors:  C A White; R D Toothaker; A L Smith; J T Slattery
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

6.  Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models.

Authors:  S Keil; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

7.  Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve.

Authors:  J E Tisdale; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model.

Authors:  L R Peterson; L L Van Etta; C E Fasching; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

9.  Comparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.

Authors:  Long-shan Zhao; Ran Yin; Bin-bin Wei; Qing Li; Zhen-yuan Jiang; Xiao-hui Chen; Kai-shun Bi
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

10.  Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits.

Authors:  L L Van Etta; C E Fasching; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.